(Q44795654)

6 December 2017

title

Growth autonomy and lineage switching in BCR-ABL-transduced human cord blood cells depend on different functional domains of BCR-ABL. (English)

1 reference

6 December 2017

Chalandon Y

1

1 reference

6 December 2017

Jiang X

2

1 reference

6 December 2017

Loutet S

3

1 reference

6 December 2017

Eaves AC

4

1 reference

6 December 2017

Eaves CJ

5

1 reference

6 December 2017

publication date

1 May 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

18

1 reference

6 December 2017

issue

5

1 reference

6 December 2017

page(s)

1006-1012

1 reference

The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Acute leukaemia in bcr/abl transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

The src homology 2 domain of Bcr/Abl is required for efficient induction of chronic myeloid leukemia-like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

The SH2 domain of bcr-Abl is not required to induce a murine myeloproliferative disease; however, SH2 signaling influences disease latency and phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

BCR-ABL accelerates C2-ceramide-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Primitive interleukin 3 null hematopoietic cells transduced with BCR-ABL show accelerated loss after culture of factor-independence in vitro and leukemogenic activity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Autocrine and paracrine effects of an ES-cell derived, BCR/ABL-transformed hematopoietic cell line that induces leukemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

A model of human p210(bcr/ABL)-mediated chronic myelogenous leukemia by transduction of primary normal human CD34(+) cells with a BCR/ABL-containing retroviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Modulation of p210(BCR-ABL) activity in transduced primary human hematopoietic cells controls lineage programming

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Episomal vectors rapidly and stably produce high-titer recombinant retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Production of high-titer helper-free retroviruses by transient transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Long-term erythropoiesis from constant numbers of CD34+ cells in serum-free cultures initiated with highly purified progenitor cells from human bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

A multipotential leukemia cell line (K-562) of human origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

BCR-ABL and v-SRC tyrosine kinase oncoproteins support normal erythroid development in erythropoietin receptor-deficient progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Replacement of the cytoplasmic domain alters sorting of a viral glycoprotein in polarized cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Erythropoietin and the Control of Red Cell Production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Expression of an activated erythropoietin or a colony-stimulating factor 1 receptor by pluripotent progenitors enhances colony formation but does not induce differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Control of hematopoietic differentiation: lack of specificity in signaling by cytokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

Evidence for a positive role of SHIP in the BCR-ABL-mediated transformation of primitive murine hematopoietic cells and in human chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403335

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2403335

1 reference

Dimensions Publication ID

6 December 2017

1000418887

0 references

1 reference